The North America veterinary clinical trials market is poised for significant expansion over the coming decade. Valued at USD 1,629.11 million in 2023, the industry is projected to surge to USD 3,841.20 million by 2032. This growth represents a compound annual growth rate (CAGR) of 10.0% during the forecast period from 2024 to 2032. The rising demand for innovative veterinary...